Your browser doesn't support javascript.
loading
Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment.
Ruigrok, Eline A M; Verkaik, Nicole S; de Blois, Erik; de Ridder, Corrina; Stuurman, Debra; Roobol, Stefan J; Van Gent, Dik C; de Jong, Marion; Van Weerden, Wytske M; Nonnekens, Julie.
Afiliação
  • Ruigrok EAM; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Verkaik NS; Department of Experimental Urology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • de Blois E; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • de Ridder C; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Stuurman D; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Roobol SJ; Department of Experimental Urology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Van Gent DC; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • de Jong M; Department of Experimental Urology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Van Weerden WM; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Nonnekens J; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Int J Mol Sci ; 23(14)2022 Jul 21.
Article em En | MEDLINE | ID: mdl-35887398
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Inibidores de Poli(ADP-Ribose) Polimerases Limite: Animals / Humans / Male Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Inibidores de Poli(ADP-Ribose) Polimerases Limite: Animals / Humans / Male Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda